American Renal Associates Holdings, Inc. (NYSE: ARA)
FILL OUT THE FORM TO FIND OUT YOUR INVESTOR RIGHTS TO POTENTIAL COMPENSATION »
Hagens Berman Sobol Shapiro LLP reminds investors in American Renal Associates Holdings, Inc. (NYSE: ARA) of the May 28, 2019 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the District of New Jersey.
If you purchased or otherwise acquired securities of ARA between August 10, 2016 and March 27, 2019 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing ARA@hbsslaw.com.
According to the complaint, Defendants misled investors about American Renal’s accounting for revenues until, on March 27, 2019, they announced investors should not rely on certain of the Company’s previously issued annual and interim financial statements.
“We’re focused on investors’ losses, the admitted improper revenue accounting that might have been intentional, and the extent to which investors may have been misled,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.